[1] |
ZENG Lijie, WANG Liang, YANG Lei .
Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
|
[2] |
ZHAO Wensi, KE Shaobo, CHEN Jiamei, WU Yong, ZHANG Caiyutian, CHEN Yongshun.
Efficacy and safety of Fruquintinib combined with immune checkpoint inhibitors in later-line treatment of patients with microsatellite stable metastatic colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 598-605.
|
[3] |
ZHAO Min, LI Rongrong, LI Boyan, WANG Wenchang, DU Shengyan, YANG Junhan, LI Huaihao, BAO Yinghui, SHI Yueting, HE Yao, LIU Miao.
Hotspots and trends of research on early esophageal cancer treatment:visual analysis based on CiteSpace
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(5): 606-605.
|
[4] |
ZHANG Zhihong, CUI Wangfei, WANG Xinzheng, CAO Ling, ZHANG Yongzhen.
Prediction model of high-risk population of upper gastrointestinal cancer and precancerous lesions
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(5): 549-555.
|
[5] |
CAO Guangwen.
Key functional molecules supporting “Cancer Evo Dev” and their roles in the prophylaxis and treatment of cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(2): 118-128.
|
[6] |
ZHANG Xuefang, DIAO Xiaoli, WANG Shuzhen.
Primary ovarian diffuse large B⁃cell lymphoma: 4 cases report and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(6): 653-658.
|
[7] |
LEI Ruijiao, ZHANG Meizhen, WANG Le, FANG Zhimei, WANG Youqing, LI Huizhang, ZHU Chen, DU Lingbin.
Analysis of screening results of urban cancer early diagnosis and treatment program in Quzhou city,Zhejiang province ,2014—2018
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 618-623.
|
[8] |
LYU Yi, ZHANG Xinyu, NIE Huifang, LI Xun.
Analysis of cancer mortality trend of urban residents in Shenyang,2013—2017
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(6): 629-634.
|
[9] |
HU Mingmiao, CHEN Mengjie, LIANG Yuejuan, WANG He.
Analysis of factors influencing pregnancy after fertility sparing treatment for malignant ovarian germ cell tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 539-543.
|
[10] |
AN Lan, RAN Xianhui, ZHENG Rongshou, CHEN Ru, WANG Shaoming, SUN Kexin, LEI Lin, ZENG Hongmei, WEI Wenqiang, ZHANG Min, ZHANG Siwei .
A comparative study on clinical diagnosis and treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(2): 126-132.
|
[11] |
LI Lu, XU Peng, LAI Xin, QI Yunxiang, FAN Ming, ZHANG Peng, LI Bosen, LI Churong, MA Daiyuan, FENG Mei.
A prospective,one-arm,multicenter phase Ⅱ clinical study of apatinib in maintenance therapy after chemoradiotherapy
for metastatic nasopharyngeal carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(4): 397-402.
|
[12] |
SU Ning, CHEN Long, Wang Lin, HE Donglei, WANG Cuiying, FENG Jun.
Surgical treament for T790M-positive lung adenocarcinoma patients with long bone metastases of extremities
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 398-402.
|
[13] |
Qin Yijia,Huang Bing,Lao Qifang,Zhang Lizhen.
Effect of different ventilation modes on the expression of S100A8 protein in patients undergoing pulmonary lobectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(6): 465-468.
|
[14] |
Liu Lingfeng,Geng Yichao,OuYang Weiwei,Ma Zhu,Li Qingsong,Li Mei, Wang Yu,Luo Daxian,Yang Wengang,Su Shengfa,He Zhixu,Lu bing.
Comparison of clinical efficacy of cisplatin combined with pemetrexed or docetaxel in stage Ⅳ lung adenocarcinoma based on propensity score matching
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 290-294.
|
[15] |
Xu Yi,Tang Shicong, Zhou xin,Xu Xiang,Huang Yaoyuan, Wang Shoufeng,Pan Hong.
Relationship between clinicopathological features of primary human non-small cell lung cancer and their tumorigenicity in nude mice
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 128-132.
|